In this study, serum CXCL9 levels were significantly elevated in COPD and ILD and correlated with KL-6, SP-A, CRP, LDH, the blood eosinophil ratio, and FEV1% (Figure 2). Here, CXCL9 is linked to interstitial lung disease.